Catherine C. Smith

12.2k citations
106 papers · 3.7k · 3 hit papers · h-index 27

Impact in

  • Hematology top 0.5%
    • Acute Myeloid Leukemia Research
    • Chronic Myeloid Leukemia Treatments
  • Genetics top 1%
    • Chronic Lymphocytic Leukemia Research
    • Myeloproliferative Neoplasms: Diagnosis and Treatment

Papers in

    • Acute Myeloid Leukemia Research 59
    • Chronic Myeloid Leukemia Treatments 48
    • Hematopoietic Stem Cell Transplantation 8
    • Chronic Lymphocytic Leukemia Research 33
    • Myeloproliferative Neoplasms: Diagnosis and Treatment 9

Catherine C. Smith

100 papers receiving 3.6k citations

Catherine C. Smith's Hit Papers

Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia 2022 · 123 citations
1230+6+12Years since publication250500750

Peers

Catherine C. Smith
Comparison fields: 5 of 139
  • Hematology 1.8k
  • Genetics 729
  • Cancer Research 695
  • Health, Toxicology and Mutagenesis 337
  • Molecular Biology 1.6k
Replace Caroline C. Philpott with:
Caroline C. Philpott United States
Yuko Yamaguchi‐Iwai Japan
Lukas C. Kühn Switzerland
Iqbal Hamza United States
Shinichiro Takahashi Japan
Ivana De Domenico United States
Adriana Donovan United States
David J. Haile United States
Issidora S. Papassideri Greece
Barbara Hoffman United States
Catherine C. Smith relative to Caroline C. Philpott United States Caroline C. Philpott's profile →
Citations per field
00.5×1.6×
Caroline C. Philpott · 1×
Citations per year

Countries citing papers authored by Catherine C. Smith

Since Specialization
Citations

This map shows the geographic impact of Catherine C. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine C. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine C. Smith more than expected).

Fields of papers citing papers by Catherine C. Smith

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine C. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine C. Smith. The network helps show where Catherine C. Smith may publish in the future.

Co-authors

The 25 scholars most cited alongside Catherine C. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Catherine C. Smith Line = papers co-authored together Catherine C. Smith links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 106 papers — load more, or switch the sort, to bring in the rest.

#Work
1
The comet assay: topical issues
Hit paper breakdown →
2008776
2
Validation of ITD mutations in FLT3 as a therapeutic target in human acute myeloid leukaemia
Hit paper breakdown →
2012542
3 2006236
4 2014172
5 2015144
6
Venetoclax Plus Gilteritinib for FLT3-Mutated Relapsed/Refractory Acute Myeloid Leukemia
Hit paper breakdown →
2022123
7 2017120
8 2020108
9 2013101
10 200986
11 198384
12 201661
13 200952
14 202051
15 202050
16 202247
17 202146
18 201445
19 200845
20 201444

About Catherine C. Smith

Catherine C. Smith is a scholar working on Hematology, Genetics, Molecular Biology, Cancer Research and Public Health, Environmental and Occupational Health, having authored 106 papers that have together received 3.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (59 papers), Chronic Myeloid Leukemia Treatments (48 papers), Chronic Lymphocytic Leukemia Research (33 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers), Hematopoietic Stem Cell Transplantation (8 papers), Cancer Genomics and Diagnostics (7 papers), Acute Lymphoblastic Leukemia research (7 papers) and Protein Degradation and Inhibitors (6 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (729 citations), Cancer Research (695 citations), Health, Toxicology and Mutagenesis (337 citations) and Molecular Biology (1.6k citations). Catherine C. Smith has collaborated with scholars based in United States, Japan and United Kingdom. Frequent co-authors include Neil P. Shah, Alexander E. Perl, Marcin Kruszewski, Isabel Gaivão, Á. Oscoz, Andrew Collins, Lisa Giovannelli, Gunnar Brunborg, Rudolf Štětina and Elizabeth A. Martin. Their work appears in journals such as Blood, Journal of Clinical Oncology, Blood Advances, Mutagenesis and Biology of Blood and Marrow Transplantation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact